Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RANBP2-like and GRIP domain-containing protein 2 (RGPD2) is a protein encoded by the RGPD2 gene in humans, belonging to the tetratricopeptide repeat domain-containing protein family. RGPD2 is one of several RANBP2-like genes clustered near the centromere of chromosome 2 and is predicted to function in GTPase activation and nuclear import processes, with a possible structural role in the nuclear pore complex. However, functional information is limited, and there is no strong evidence it serves as a direct therapeutic target, receptor, enzyme, or transporter[1][3][5]. RGPD2 is primarily annotated as a structural or regulatory protein related to the nuclear transport machinery, not as a therapeutic target[5]. No interacting drugs, clinical biomarkers, or disease associations established for clinical pharmacology were found in current publicly available databases[1][5]. While its structure includes tetratricopeptide repeats, best known for facilitating protein-protein interactions, the precise physiological and disease functions of RGPD2 remain largely uncharacterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RANBP2-like and GRIP domain-containing protein 2 (RGPD2).